• Projected Long-Term Outcomes in Patients with Type 1 Diabetes Mellitus Treated with Faster-Acting Insulin Aspart Versus Conventional Insulin Aspart in the UK Setting

    Nov 1, 2016, 00:00

  • The Association Between Disability And Early Exit From Work In Osteoarthritis

    Nov 1, 2016, 00:00

  • Type 2 Diabetes- How Much Does it Cost During the First 8 Years after the First Antidiabetic Treatment? A Dynamic Approach from the French National Health Insurance

    Nov 1, 2016, 00:00

  • The Effect of Therapeutic Drug Monitoring in Patients Complian An Improvement in Drug Efficacy and Corresponding Reduction in Toxicity Using Aminoglycosides

    Nov 1, 2016, 00:00

  • Assessing Primary Care Practice Capacity For Quality Improvement- Preliminary Findings From Healthy Hearts in The Heartland (H3)

    Nov 1, 2016, 00:00

  • Bayesian Network of Disease History

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Diagnostic Tests for People At Risk of Non-Alcoholic Fatty Liver Disease (NAFLD) in The UK

    Nov 1, 2016, 00:00

  • The Determinants Of Innovative Drugs Prices- The Case Of Oncology Drugs, Comparative Analysis

    Nov 1, 2016, 00:00

  • Equity of Government Subsidy in Health Care- A Case Study in China

    Nov 1, 2016, 00:00

  • Quinolones Utilization In Two Tertiary Hospitals In Nigeria; Exploring Drug Use Towards Improved Treatment Outcomes

    Nov 1, 2016, 00:00

  • Upcoming Regulations on Insurance Reimbursement Standard in China- Chanllanges and Opportunites for Mncs

    Nov 1, 2016, 00:00

  • Treatment Satisfaction Of Osteoporosis Medication In Postmenopausal Women Of Korea; Results From The Study Of Osteoporosis Medication Adherence And Satisfaction In Postmenopausal Women

    Nov 1, 2016, 00:00

  • Project Octo-Pills- Management Of Polypharmacy And Drug Related Problems From Hospital To Community Pharmacies – An Octopus Initiative For The Silver Tsunami

    Nov 1, 2016, 00:00

  • Pharmaceutical Tracking System- An Improvement in Data Accuracy and Uses

    Nov 1, 2016, 00:00

  • Analysing the Prescribing Landscape for Oral Anticoagulants

    Nov 1, 2016, 00:00

  • Diagnostic Accuracy of Assessment Methods for Diagnosing Diabetic Peripheral Neuropathy (DPN)- A Systematic Review and Meta-Analysis- An Evidence Based Approach

    Nov 1, 2016, 00:00

  • Comparing The EQ-5D-5L Value Sets Across Diferent Countries – Impact on Inpertretation of Clinical Study Results

    Nov 1, 2016, 00:00

  • Investigation Of The Work Ability Of Nurses And Its Influencing Factors

    Nov 1, 2016, 00:00

  • Efficacy and Safety of Azathioprine for Multiple Sclerosis- A Rapid Review

    Nov 1, 2016, 00:00

  • Complementary and Alternative Medicine use and Its Association with Quality of Life Among Cancer Patients Receiving Chemotherapy in Ethiopia- A Cross Sectional Study

    Nov 1, 2016, 00:00

  • Patient Reported Asthma Control In Comparison To Physician Assessed Asthma Control- A Cross-Sectional Analysis of The Act Questionnaire Based on 673 Asthma Patients

    Nov 1, 2016, 00:00

  • Comparing Eq-5d-3l And Eq-5d-5l In A General Population

    Nov 1, 2016, 00:00

  • Childhood Stunting, Wasting and Obesity in Indonesia- Evidence from the Indonesian Family Life Survey

    Nov 1, 2016, 00:00

  • Using Clinical Trial and Real World Data to Bridge Efficacy to Effectiveness of Fingolimod in Multiple Sclerosis Patients

    Nov 1, 2016, 00:00

  • Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Mexico

    Nov 1, 2016, 00:00

  • Comparing Costs from a Pragmatic Randomised Trial to Published Modelling-Based Estimates- An Example from Prostate-Cancer Screening

    Nov 1, 2016, 00:00

  • Combining A Real-World Observational Study And A Network Meta-Analysis of Randomised Controlled Trials To Determine Relative Treatment Effects In Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Dose Extension and Costs of Lanreotide Autogel 120 Mg Used in Routine Neuroendocrine Tumors Care In Poland – 2- Years Data From Lanro-Net Study

    Nov 1, 2016, 00:00

  • Beyond Cervical Cancer- The Cost-Effectiveness Of Hpv Vaccination In The Netherlands

    Nov 1, 2016, 00:00

  • Effect of Drug Cost-Sharing Change on Non-Adherence to Essential Medications for Acute Coronary Syndrome- A Population Based Natural Experiment

    Nov 1, 2016, 00:00

  • Relationship between Insulin Adherence and Health Care Resource Utilization among Type 2 Diabetes Patients in China

    Nov 1, 2016, 00:00

  • Knowledge And Participation Rate on Cervical Cancer Screening Among Romany Minority Population

    Nov 1, 2016, 00:00

  • Validity Of The Eq-5d-Youth In Asthmatic Children

    Nov 1, 2016, 00:00

  • German Travelers’ Preferencences For Vaccines Against Travel-Related Illnesses

    Nov 1, 2016, 00:00

  • Treatment Patterns of Relapsed and Refractory Multiple Myeloma in Europe (EU-28)

    Nov 1, 2016, 00:00

  • Actuarial Approaches To Modelling and Mitigating Financial Uncertainty in Recommending New Drugs and Health Technologies

    Nov 1, 2016, 00:00

  • A Comparison of National Guidelines for Network Meta Analysis

    Nov 1, 2016, 00:00

  • Towards Better Coordination and More Efficient Patient Pathways in Copd

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor For The Treatment of Heart Failure From Public Health Perspective in Chile

    Nov 1, 2016, 00:00

  • Health-Economic Analysis of The Use of Sensor-Augmented Pump with Predictive Suspend Function (SAP) Therapy in Sweden Compared to Insulin Pump Therapy Alone (CSII), in Type 1 Diabetic Patients

    Nov 1, 2016, 00:00

  • Work and Income Loss Consideration Among Patients With Herpes Zoster When Completing A Quality Of Life Questionnaire

    Nov 1, 2016, 00:00

  • ASSESSMENT OF PET/CT USE IN RADIOTHERAPY PLANNING VERSUS CT SCANS USE ONLY

    Nov 1, 2016, 00:00

  • Time To Formal ‎Reimbursability ‎For Innovative ‎Drugs In Italy ‎

    Nov 1, 2016, 00:00

  • Quality of Life of Stroke Survivors and Their Informal Caregivers- A Prospective Study

    Nov 1, 2016, 00:00

  • Single-Arm Trials in Systematic Reviews- Are They Adequately Captured by Existing Search Filters?

    Nov 1, 2016, 00:00

  • Effect Of A Pay-For-Performance Program For Diabetes On Health Status (Eq-5d) In Taiwan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Highly Innovative Treatments For Hepatitis C- The Case Of Ledipasvir/Sofosbuvir In A Greek Healthcare Setting

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Dapagliflozin Versus Glimepiride as Monotherapy in Patients with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • A Novel Method for Evaluating Value Assessment Frameworks

    Nov 1, 2016, 00:00

  • Retrospecive Patient Chart Study to Evaluate Real Life Treatment and Event Rate of Patients Surviving Their Myocardial Infarction for at Least 12 Months

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of A Potential Treatment Introduction for Anorexia-Cachexia in Non-Small Cell Lung Cancer Patients

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Rivaroxaban For Treatment of Deep Vein Thrombosis And Pulmonary Embolism In Greece

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los And Costs) of Adhesion Related Complications after Liver Resection Surgery

    Nov 1, 2016, 00:00

  • Prompt Value Assessment Of Breakthrough Interventions With Limited Outcome Data

    Nov 1, 2016, 00:00

  • Societal Impact of Pain (SIP) 2016 - 8 Policy Recommendations- Time for Action

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Laparoscopic and Open Surgery for Rectal Cancer

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Dabigatran for The Prevention of Stroke in Iranian Atrial Fibrillation Patients

    Nov 1, 2016, 00:00

  • Lost in Translation- Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction

    Nov 1, 2016, 00:00

  • Herpes Zoster And Postherpetic Neuralgia- Quality Of Life And Healthcare Utilization, A German Study

    Nov 1, 2016, 00:00

  • Assessment of Knowledge of Urinary Tract Infection (UTI) Amongst School-Going Adolescent Girls

    Nov 1, 2016, 00:00

  • Estimating the Value of Treatment for Fabry Disease- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Quality of Life Measured with Eq-5d in Patients with Major Depressive Disorder in Japan

    Nov 1, 2016, 00:00

  • Increasing Trend Of Health Related Quality Of Life Awareness For Diabetic Care Among Indian Scientists

    Nov 1, 2016, 00:00

  • The Evaluation of Relationship between Regular Inspection and Committing Major Malpractice in Pakdasht Pharmacies

    Nov 1, 2016, 00:00

  • Combined use of Administrative Data Flows with Innovative Biologic Drug Registries to Assess Therapeutic Appropriateness- An Italian Regional Experience

    Nov 1, 2016, 00:00

  • Factors Associated with The Mental and Physical Health-Related Quality of Life (HRQOL) of Asthma Patients- A Cross-Sectional Analysis Based On 673 Patients

    Nov 1, 2016, 00:00

  • Good Enough For Policy Work? Study-Design Challenges In Implementing Stated-Preference Methods For Complex Health-Care Technologies

    Nov 1, 2016, 00:00

  • Similarities and Differences of Risk Sharing Arrangements in Australia, United Kingdom, Italy, and Korea

    Nov 1, 2016, 00:00

  • Future Innovative Therapies for Parkinson's Disease May Question Sustainability of Our Health Care System

    Nov 1, 2016, 00:00

  • Assessment of Utility for Heart Failure using Visual Analogue Scale(VAS), Time-Trade off(TTO) and Euroqol-5 Dimension(EQ-5D) in the Korean General Population

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Fingolimod Vs Brace Cycling Followed By A Switch To Fingolimod In Patients Failing Prior Treatment

    Nov 1, 2016, 00:00

  • A Proposed Holistic Conceptual Framework for Barriers to Medication Adherence in Diabetes

    Nov 1, 2016, 00:00

  • How Much are Chinese Willing to Pay for the Health Improvement?

    Nov 1, 2016, 00:00

  • Evaliation of Utility Index of Quality of Life In Hepatitis Patients in Japan

    Nov 1, 2016, 00:00

  • Lenalidomide for Treating Multiple Myeloma After 1 Prior Treatment; An Application of Multi-State Markov Modelling for the Extrapolation of Patient Level Survival Data

    Nov 1, 2016, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs Adalimumab Based on A Matching-Adjusted Indirect Comparison For The Treatment of Ankylosing Spondylitis From A German Payer Perspective

    Nov 1, 2016, 00:00

  • A General Model for The Estimation of Societal Costs of Lost Production and Informal Care In Italy

    Nov 1, 2016, 00:00

  • Real Time Patient Reported Outcomes Assessment in Routine Rheumatology Clinic - Feasibility Study of Myra Touch

    Nov 1, 2016, 00:00

  • The Economic Burden of Heart Failure in Greece From A Social Security System Perspective

    Nov 1, 2016, 00:00

  • Cost-Sharing In Healthcare- An Approach For Pharmaceutical Care In Greece

    Nov 1, 2016, 00:00

  • Effects of Opioid use with and without Over-The-Counter Analgesics on Economic Outcomes Among Adults with Pain in the United States

    Nov 1, 2016, 00:00

  • Comparative Analysis of Clinical Trial Attributes in Pivotal Studies for Orphan vs. Non-Orphan Oncology Products FDA-Approved between 2011 and 2015

    Nov 1, 2016, 00:00

  • Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) Model

    Nov 1, 2016, 00:00

  • A Value for Money Threshold for New Technologies for Very Rare Diseases- Does the Nice Highly Specialised Committee Employ One?

    Nov 1, 2016, 00:00

  • Reducing Medical Claims Cost to Ghana’s National Health Insurance Scheme- Paper-Based Versus Electronic-Based Claims Review

    Nov 1, 2016, 00:00

  • Personalized Adaptive Rewards Versus Incentives to Motivate Sustainable Healthy Behavioral Change- A Neo-Maslowian Conceptual Model

    Nov 1, 2016, 00:00

  • Incorporating Biometric Data from Wearable Activity Trackers with Study Data in France and the UK

    Nov 1, 2016, 00:00

  • Alemtuzumab Budget Impact For Multiple Sclerosis Treatment In Spain

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing An Etanercept Biosimilar (Benepali®) For The Treatment of All Licensed Adult Etanercept Indications In The UK

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2016, 00:00

  • Innovative Approach To Keeping Evidence Current And Guidelines Living

    Nov 1, 2016, 00:00

  • Budget Impact Model Of Indacaterol/Glycopyrronium In The Treatment Of Copd In Italy Based On Flame Study

    Nov 1, 2016, 00:00

  • Economic Analysis of Endovascular Interventions for The Treatment of Femoropopliteal Peripheral Artery Disease in Austria

    Nov 1, 2016, 00:00

  • Racial Differences in Cardiovascular Disease in The United States- Healthcare Resource Utilization and Costs

    Nov 1, 2016, 00:00

  • Methods for Time-Varying Exposure – A Literature Review

    Nov 1, 2016, 00:00

  • Use of Nimotuzumab in The Treatment of Locally Advanced Esophageal Cancer in Real World

    Nov 1, 2016, 00:00

  • Investigating the Implementation of Adverse Events in Economic Models- A Systematic Literature Review in Multiple Sclerosis and Human Immunodeficiency Virus

    Nov 1, 2016, 00:00

  • Discordance Between Knowledge of Cardiovascular Risk Factors and Ideal Cardiovascular Health in Hong Kong Adults

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Xydalba from the Perspective of Italian National Health System

    Nov 1, 2016, 00:00

  • What is Government's Responsibility for China's Universal Health Security? An Outlook for a National Health Security System

    Nov 1, 2016, 00:00

  • Differences in Cost-Effectiveness Estimates for Chronic Hepatitis C Treatment Among Cohort Markov Model, Markov Microsimulation and Discrete Event Simulation

    Nov 1, 2016, 00:00

  • The Epidemiology and Cardiovascular Disease Risk Assessment of Patients Currently on Lipid Lowering Treatment with Statin- Nationwide Cross-Sectional Study in Korea

    Nov 1, 2016, 00:00

  • Measuring Income-Related Inequity In Self-Assessed Health Using The EQ-5D In 7 Countries

    Nov 1, 2016, 00:00

  • Cost Analysis of Different Sequential Treatment Regimens for Metastatic Renal Cell Carcinoma in China

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Crizotinib Among ALK+ NSCLC Patients Across The United States, Western Europe, and Japan

    Nov 1, 2016, 00:00

  • The Direct Cost-Components in Pulmonary Arterial Hypertension- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2016, 00:00

  • Health Technology Assessment In Brazil- Metrics From The Reports Of The National Commission For Incorporation Of Technologies (Conitec)

    Nov 1, 2016, 00:00

  • Mcda Application In Central And Eastern Europe- Selection Of The Most Important Criteria Based On Examples

    Nov 1, 2016, 00:00

  • Systematic Review and Meta-Analysis of Risperidone for the Treatment of Schizophrenia

    Nov 1, 2016, 00:00

  • Economic Burden of Hospitalization for Hepatic Encephalopathy in Fran An Analysis of Cost Discriminating Factors By Patient Profile

    Nov 1, 2016, 00:00

  • Investigation About Influence Of Management Strategy In National Hospital Organization (Nho) Hospitals By The Revision Of Medical Fee Schedule

    Nov 1, 2016, 00:00

  • Sampling of Commonly used Population Characteristics- Is A Normal Approximation Valid?

    Nov 1, 2016, 00:00

  • Cost-Utility Evaluation of Insulin Glargine 300 (GLA-300) Versus Insulin Glargine 100 (GLA-100) in Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Synthesis of Binary Outcome Data on the Log-Odds and Absolute Risk Scales – A Case Study in Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • How time and severity increases the overall cost and resource utilization of patient with severe liver disease. Main burdens and consequences to health system

    Nov 1, 2016, 00:00

  • Food for Thought (But Not Too Much) for Health Economic Analyes of Nutritional Interventions in Obesity

    Nov 1, 2016, 00:00

  • Systematic Review And Meta-Analysis of Accuracy of Diagnostic Tests For Screen Detection of Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Adding Bedaquiline To Background Drug Regimens For The Treatment of Multidrug-Resistant And Extensively-Resistant Tuberculosis In Italy

    Nov 1, 2016, 00:00

  • Comparison Between Cancer Drugs Assessment In Portugal And United Kingdom

    Nov 1, 2016, 00:00

  • Implementation of Conditional Reimbursement Schemes in HTA Practi Experiences from the Netherlands

    Nov 1, 2016, 00:00

  • Big Data In Healthcare - Opportunities And Challenges

    Nov 1, 2016, 00:00

  • Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Germany Based on Sick Fund Data Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of A Bone Transplant Fixation “Shark Screw” Transplant Compared To Metal Devices In Oesteosynthesis In Austria

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life In Patients with Systemic Lupus Erythematosus (SLE)- A Spanish Study Based on Patient Reports

    Nov 1, 2016, 00:00

  • Analysis on the Utilization Status of Essential Medicines in Beijing's Community Health Institutions

    Nov 1, 2016, 00:00

  • Implementation Of The Insurance Programs For Catastrophic Diseases In China- A Qualitative Study

    Nov 1, 2016, 00:00

  • Cost of Treatment of Pancreas Transplantation Therapy and Insulin Pump Therapy of Type I Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving While Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in France

    Nov 1, 2016, 00:00

  • Potential Factors Predicting The Response in The Treatment of Attention-Deficit/Hyperactivity Disorder Children with Atomoxetine in Asia Pacific Region

    Nov 1, 2016, 00:00

  • Clinical Trials Scenario In Brazil- Study And Sponsor Profiles

    Nov 1, 2016, 00:00

  • Clinical and Economic Analysis of Eyelid Hygiene Complex for Patients with Meibomian Glands Dysfunction in Russia

    Nov 1, 2016, 00:00

  • Estimation of The Direct Cost of COPD In Bulgaria

    Nov 1, 2016, 00:00

  • Adverse Drug Reactions of Radiographic Contrast Media Used in Computed Tomography and Magnetic Resonance Imaging in India

    Nov 1, 2016, 00:00

  • Comorbidites and Patient-Reported Outcome after Total Hip Arthroplasty

    Nov 1, 2016, 00:00

  • Costs of Adverse Events Associated with Cancer Therapies in Non-Small Cell Lung Cancer in France

    Nov 1, 2016, 00:00

  • Patterns of Care Among Pancreatic Cancer Patients- Findings from a u.s. Real-world claims-based analysis

    Nov 1, 2016, 00:00

  • The Quev Score- A Quantitative Evaluation of the Quality of Clinical Evidence in HTA

    Nov 1, 2016, 00:00

  • Risk Elements and Drug Utilization in Stroke Patients

    Nov 1, 2016, 00:00

  • The Management and Costs of Multiple Myeloma in Gree Mapping the Local Treatment Pathway and Associated Resource Use

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Generic Versus Brand Form of Deferasiroix N The Management of B-Thalassemia Patients with Chronic Iron Overload- An Egyptian Health Care Provider Perspective

    Nov 1, 2016, 00:00

  • The Dynamics of Quality of Life In Children With Uncontrolled Severe Persistent Asthma

    Nov 1, 2016, 00:00

  • Outcomes for Older Patients with Acute Myeloid Leukemia (AML)- Multiple Hospitalizations and High Mortality Rates

    Nov 1, 2016, 00:00

  • Comparisons of Treatment Patterns for Type 2 Diabetes Mellitus (T2DMm) in Japan and in the United States

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Neoadjuvant Chemotherapy with Pertuzumab, Trastuzumab and Docetaxel in Patients With HER2+ Breast Cancer in Spaincost-Utility Analysis of Neoadjuvant Chemotherapy with Pertuzumab, Trastuzumab and Docetaxel in Patien ...

    Nov 1, 2016, 00:00

  • Management of Metastatic Colorectal Cancer Patients- A Methodological Approach to Identify Treatment Lines

    Nov 1, 2016, 00:00

  • The Assessment of Value for Medical Devices- Using Real World Evidence (RWE) to Quantify Unmet Needs in Diabetes Management

    Nov 1, 2016, 00:00

  • Assessing Real Consumption of Medications for Fertility Treatments in Ukraine

    Nov 1, 2016, 00:00

  • The Apheresis- Database (APHDA)-Project- Patient Characteristics Treatment Patterns of Apheresis Patients in Germany

    Nov 1, 2016, 00:00

  • Impact of Poverty on Health Care Utilization in the Elderly

    Nov 1, 2016, 00:00

  • A Health Outcomes Model Showing Stroke Prevention in Atrial Fibrillation and Cost-Savings in England

    Nov 1, 2016, 00:00

  • Integration Of Basic Attention To The Specialized Attention Network In Brazil’s Health System

    Nov 1, 2016, 00:00

  • Direct Healthcare Costs and Clinical Outcomes of Open Abdominal Aortic Aneurysm Repair in Spain. Recapta Study

    Nov 1, 2016, 00:00

  • The Quality of Pharmacoeconomic Publications in Breast Cancer Pharmacotherapies in China

    Nov 1, 2016, 00:00

  • The Influence Of Price Regulation Method On Price Trajectory – Assessment Of Cancer Drug Prices In Usa, The Uk And Israel

    Nov 1, 2016, 00:00

  • External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Pirfenidone For The Treatment of Mild To Moderate Idiopathic Pulmonary Fibrosis (IPF) Compared To Best Supportive Care And Nintedanib From The Italian NHS Perspective

    Nov 1, 2016, 00:00

  • Regulatory Agencies Perspective on Progression-Free-Survival (PFS)

    Nov 1, 2016, 00:00

  • Evaluation Of The Impact Of Pharmacists Qualification And Years Of Practice On Pharmaceutical Care Services In Community Pharmacy Practice In Enugu Nigeria

    Nov 1, 2016, 00:00

  • Cost Minimization Of 10% Intravenous Immunoglobulin Against Other Intravenous Immunoglobulin For Treating Primary Inmunodeficiencies

    Nov 1, 2016, 00:00

  • The Structure and Vascularization of Choroid Plexus of Brain in Children Aged From 0–3 Years Old

    Nov 1, 2016, 00:00

  • The Societal and Humanistic Burden of Small Cell Lung Cancer (SCLC)- A Systematic Review of Societal Impact and Health-Related Quality Of Life (HRQOL) Literature

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis To Estimate The Cost Savings from Alectinib on Patients With Anaplastic Lymphoma Kinase (ALK) Positive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) Previously Treated with Crizotinib

    Nov 1, 2016, 00:00

  • A Cohort Study to Access the Impact of Paediatric Use of Proton Pomp Inhibitor on the Risk of Community Acquired Infections €“ Utopie

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Newer Antiepileptic Drugs (Aeds) For Management of Partial Epilepsy In Children In Malaysia

    Nov 1, 2016, 00:00

  • Extrapolation with Patient Level Time-To-Event Data in Various Disease Areas- A Review of Current Recommendations and Gaps

    Nov 1, 2016, 00:00

  • Impact of Medication Therapy Management Service Provided by Clinical Pharmacists on Drug Therapy of Patients Undergoing Hemodialysis

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Including A Pentavalent (Hib-Hbv-Dtp) Vaccine In The National Childhood Immunization Schedule Of Iran

    Nov 1, 2016, 00:00

  • Association Between Eq-5d And Changes in Asthma Symptoms, Severity, and Qol In Patients With Severe Eosinophilic Asthma

    Nov 1, 2016, 00:00

  • The Economic Burden of Hypertension in Latin America

    Nov 1, 2016, 00:00

  • Racial/Ethnic Disparity in Individual Economic Burden of Diabetes in the USA

    Nov 1, 2016, 00:00

  • Cost Effectiveness Evaluation of Fracture Liaison Services for the Management of Osteoporosis in Sweden

    Nov 1, 2016, 00:00

  • Evaluating the Relative Effectiveness of Two Malnutrition Risk Assessment Tools in Surgical Population at a Tertiary Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Epidemiology and Costs of Psoriatic Arthritis in Germany – A Retrospective Claims Data Analysis

    Nov 1, 2016, 00:00

  • Application of Value of Information Analysis To Minimize Decision Risk In Malaysia

    Nov 1, 2016, 00:00

  • Cost Of Dengue And Cost-Effectiveness Of The Dengue Vaccine In Panama

    Nov 1, 2016, 00:00

  • Effectiveness of A Referral Program For Early Arthritis Diagnosis At Primary Care Centers In Portugal - Final Results From The Siara Study

    Nov 1, 2016, 00:00

  • The EQ-5D-5L Instrument Demontrates Better Performance Compared With The EQ-5D-3L In Psoriatic Patients

    Nov 1, 2016, 00:00

  • Evaluating the Effectiveness of Treatments of Opioid use Disorder Based on Recovery Outcomes- How to Bridge the Disconnect Between Clinical Trial Outcomes and Recovery Outcomes?

    Nov 1, 2016, 00:00

  • Valuing Cancer-Related Premature Mortality- A Comparison of Consumer-Led Versus Producer-Led Approaches

    Nov 1, 2016, 00:00

  • Pro Instruments Used In Studies Published Since 2005- Which Populations And Diseases Have Had The Most Tools Developed?

    Nov 1, 2016, 00:00

  • A Review of Health State Utility Values Used in UK Nice Appraisals in Advanced NSCLC

    Nov 1, 2016, 00:00

  • Direct Costs and Healthcare Resource Use Associated with Advanced Non-Small Cell Lung Cancer Management in Previously Treated Patients in Portugal

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Secukinumab In Moderate To Severe Plaque Psoriaris, Ankylosing Spondylitis And Psoriatic Arthritis In France

    Nov 1, 2016, 00:00

  • Is the Lack of Inclusion on the National Drug Reimbursement List the end of the World for Access?

    Nov 1, 2016, 00:00

  • The Relationship Between Antenatal Care And Health Facility Delivery

    Nov 1, 2016, 00:00

  • A Population Based Diabetes Drug Utilization Analysis in Chinese Community- A Retrospective Database Study

    Nov 1, 2016, 00:00

  • Disease Burden of Herpes Zoster in Taiwan- A Five-Year Population-Based Study

    Nov 1, 2016, 00:00

  • Flexibly Modelling HBA1C Progression in Type 2 Diabetes to Estimate the Impact of Clinical Inertia on Costs and Quality Adjusted Life Years

    Nov 1, 2016, 00:00

  • The Effect of Physical Activity on the Mental and Emotional State of University Students

    Nov 1, 2016, 00:00

  • Icpc-2 Episode-Based Health-Related Quality Of Life And Three Months Effectiveness In Three Finnish Primary Health Care Settings

    Nov 1, 2016, 00:00

  • Access To Anti-Infective Medicines For Systemic Use In Armenia

    Nov 1, 2016, 00:00

  • Quantifying Informal Versus Formal Care, and Financial Caregiver Burden, for Stroke Patients in Asia- A Structured Literature Review

    Nov 1, 2016, 00:00

  • Unlocking Established Products Patient and Societal Value in Additional Indications

    Nov 1, 2016, 00:00

  • The GM Ahsn Af Landscape Tool- A Shared Data Platform to Identify Health and Economic Opportunities to Reduce Incidence of Stroke Through Effective Anticoagulant Management of Patients with Atrial Fibrillation in Greater Manchester

    Nov 1, 2016, 00:00

  • Patient Focused Technology Enabled Programs Improve Outcomes in Primary Total Hip (THA) Total Knee Arthroplasty (TKA) Patients

    Nov 1, 2016, 00:00

  • The Impress (International Multiple Sclerosis) Study; Results On The Socio-Economic Burden, Health Related Quality Of Life And Experience Of Multiple Sclerosis Patients In France

    Nov 1, 2016, 00:00

  • Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma

    Nov 1, 2016, 00:00

  • Open Versus Endovascular Repair in Patients with Abdominal Aortic Aneurysm in Spain ─ A Cost Comparisson

    Nov 1, 2016, 00:00

  • Safety And Effectiveness of Autologous Platelet Rich Plasma Therapy For Lateral Epicondylitis- Systematic Reviews

    Nov 1, 2016, 00:00

  • Improving the System of Healthcare Provision for Patients with Diffuse Toxic Goiter in Ukraine

    Nov 1, 2016, 00:00

  • Quality of Life of Patients Treated for Multiple Myeloma (MM) in France in a Real-World Setting

    Nov 1, 2016, 00:00

  • Sacubitril/Valsartan Estimated Cost Savings Based on Paradigm-HF Results

    Nov 1, 2016, 00:00

  • Quantifying the Health Economic Value Associated with Unit Changes in HBA1C in Type 1 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Economic Assessment of Dydrogesterone Compared with Progesterone for the Treatment of Threatened Andhabitual Miscarriage in China

    Nov 1, 2016, 00:00

  • The Burden of Comorbid Allergic Rhinitis and Asthma

    Nov 1, 2016, 00:00

  • War Rages Between Infliximab Biosimilars and Their Originator

    Nov 1, 2016, 00:00

  • Impact Of Patients Counselling On Mindful Attention Awareness And Stress In Cancer Patients

    Nov 1, 2016, 00:00

  • Direct Medical Costs Associaed with Diabetic Complicaitons in Patients with Type 2 Diabetes in Us and South Korea

    Nov 1, 2016, 00:00

  • Real-World Evidence of Ruxolitinib In The Treatment of Myelofibrosis- Experince of A Portuguese Hospital Center

    Nov 1, 2016, 00:00

  • Payer Requirements in the Treatment of Chronic Heart Failure

    Nov 1, 2016, 00:00

  • Evaluation of the Effect of Pharmacogenetic Dosing of Warfarin- Should Non-Randomized Clinical Studies be Considered?

    Nov 1, 2016, 00:00

  • Extracting Dosage Per Day From Free-Text Medication Prescriptions

    Nov 1, 2016, 00:00

  • Skeletal-Related Events (SRES) and Renal Function in Patients with Symptomatic Multiple Myeloma (MM)- Results from Belgium, France, Germany, Italy, Spain, Switzerland and The United Kingdom

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apremilast In Moderate-To-Severe Psoriasis In Canada

    Nov 1, 2016, 00:00

  • Medication Safety Warnings- Awareness, Source and Actions of Consumers in the U.S

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Panitumumab Vs Cetuximab as Monotherapy for Chemo-Refractory Patients with WT KRAS MCRC in Mexico

    Nov 1, 2016, 00:00

  • The Public Acceptance And Willingness-To-Pay (Wtp) Of Dengue Vaccine In Penang, Malaysia- Assessment with A Contingent Valuation Study

    Nov 1, 2016, 00:00

  • Validity and Reliability of Three New Instruments for Parents and Children Assessing Nutrition and Physical Activity Behaviors, Environment and Knowledge and Health in Childhood and Adolescence in Greece During the Economic Recession- Data ...

    Nov 1, 2016, 00:00

  • Kangaroo Mother Care- A Cost Effective and an Alternate Method to Manage Hypothermia in Low Birth Weight Babies for Better Clinical Outcome

    Nov 1, 2016, 00:00

  • Differences In Pricing Policies For Generic And Biosimilar Medicines

    Nov 1, 2016, 00:00

  • Risk Share Agreements (RSA), Product Listing Agreements (PLA) or Patient Access Schemes (PAS) - All the Same or Different?

    Nov 1, 2016, 00:00

  • Mapping of The Biosimilar Drug Policy in 10 Central Eastern European Countries

    Nov 1, 2016, 00:00

  • A Health Technology Assessment of Single Balloon Valvuplasty

    Nov 1, 2016, 00:00

  • The Incidence of Hypoglycemia in Type II Diabetes Mellitus (T2DM) Patients Treated with Insulin Therapy in Combination with DPP-4 in Greece. A Sub-Analysis of Hypo 2 Study

    Nov 1, 2016, 00:00

  • Methodological Review of Survival Models- Application to A Persistence Analysis Based on Long Acting Parenteral Antipsychotic in Retail Pharmacies in France

    Nov 1, 2016, 00:00

  • A Retrospective Study on Association Between Change In Bmi And Incidence Of Hypertension Using A Health Care Database In Japan

    Nov 1, 2016, 00:00

  • The Uk Early Access To Medicines Scheme- A 2-Year Status Update On Successes, Issues And Controversies

    Nov 1, 2016, 00:00

  • Day Surgery Vs Regular Admission- Activity-Based Cost Analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Procedures From Hospital Perspective

    Nov 1, 2016, 00:00

  • Generating Health Utility Values From US SF-36 Scores For French Assessment- Comparison of 3 Mapping Methods

    Nov 1, 2016, 00:00

  • The Impact of Economic Crisis on Drug Consumption and Pharmaceutical Expenditure in Greece

    Nov 1, 2016, 00:00

  • Construct Validity Of The 10-Year Time Trade-Off Method In Psoriasis Patients

    Nov 1, 2016, 00:00

  • Utility By Treatment Line In Multiple Myeloma; Analysis of Over 9000 EQ-5Q-3L Questionnaires from the Emmos Registry

    Nov 1, 2016, 00:00

  • Antibiotic Treatment of Uncomplicated Urinary Tract Infection In Women- A Comparative Cost-Effectiveness Study

    Nov 1, 2016, 00:00

  • Phase III Trial of Recombinant Human Parathyroid Hormone in Hypoparathyroidism- A Post-HOC Analysis of Change in Health-State Utility Among Responders

    Nov 1, 2016, 00:00

  • Utilization Of Physiotherapy Visits Completed In Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • The Case For Bayesian Methods In Benefit-Risk Assessment- Overview And Future Directions

    Nov 1, 2016, 00:00

  • Trends of Including Pharmacoeconomics Course in the Undergraduate Pharmacy Curriculum

    Nov 1, 2016, 00:00

  • Adjustment Of OS In Crystal For Post-Study Anti-Cancer Therapies

    Nov 1, 2016, 00:00

  • Economic Modeling of Risk-Adapted Screen-and-Treat Strategies in Women at High-Risk for Breast or Ovarian Cancer

    Nov 1, 2016, 00:00

  • Estimation of Willingness to Pay for a Quality-Adjusted Life Year on a Cure

    Nov 1, 2016, 00:00

  • Safety and Efficacy of High-Potency Statin and Ultra-Low LDL in Chinese Patients with Established Cardiovascular Disease- Practice Impact of the New Cholesterol Guidelines

    Nov 1, 2016, 00:00

  • Changes of The Reimbursement Recommendations Focused on Oncology Drugs Before and after The Implementation of The 2013 Benefit Enhancement Policy in Korea

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Heart Failure with Preserved Ejection Fraction (HF-PEF) in Turkey- The Results of A Delphi Panel

    Nov 1, 2016, 00:00

  • Rare and Intractable Disease Policy Reform in Japan- A Before and After Analysis

    Nov 1, 2016, 00:00

  • Australian Influenza National Surveillance Data (2009 to 2014) – Variations by Sex, Age Group, and Influenza Type

    Nov 1, 2016, 00:00

  • Cost Comparison in the Management of the Renal Cell Carcinoma with in Spain- Pazopanib vs. Sunitinib

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1b Hcv In Greece

    Nov 1, 2016, 00:00

  • Evaluation of Quality of Pharmacoeconomic Studies in Asia Pacific and Identification of Influencing Variables

    Nov 1, 2016, 00:00

  • Absence of Price-Prevalence Correlation in Orphan Drugs in Italy

    Nov 1, 2016, 00:00

  • “Best Supportive Care” or “Therapy According to Physician's Choice” as Appropriate Comparator for German HTA Dossiers – An Underestimated Chance or Risk for the Benefit Assessment?

    Nov 1, 2016, 00:00

  • Feasibility of Electronic Medical Records in Australia, China, and Japan to Support Novelty (A Novel Observational Longitudinal Study of Patients with Asthma and/or COPD)

    Nov 1, 2016, 00:00

  • Trends In Outpatient Use Of Antibiotics In Croatia

    Nov 1, 2016, 00:00

  • Reflecting Uncertainty in Early HTA When Evidence on Parameter Distributions is Lacking- A Comparison of Methods

    Nov 1, 2016, 00:00

  • Policies for Use of Real-World Data in Health Technology Assessment- A Comparative Study of 6 HTA Agencies

    Nov 1, 2016, 00:00

  • The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Greece. “RECAP-DM”

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Radial Access Versus Femoral for Diagnostic Cardiac Catheterization and Coronary Intervention in Colombia

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Practice Towards Hepatitis B Among Medical College Students of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis Of Tedizolid For The Treatment Of Acute Bacterial Skin And Skin Sub-Structure Infections (Absssi) In Greece

    Nov 1, 2016, 00:00

  • Accounting for the Imperfect External Validity of Discrete Choice Experiments When Predicting Demand

    Nov 1, 2016, 00:00

  • The Economic Evaluation of Bone-Anchored Hearing AIDS (BAHAS)- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Antibiotic Utilisation and Expenditure in Ireland

    Nov 1, 2016, 00:00

  • The Prevalence of Atypical Antipsychotic Medication Use For Pediatric Psychosis in Korea

    Nov 1, 2016, 00:00

  • Knowledge of Blood Pressure Control Programs In University Students

    Nov 1, 2016, 00:00

  • Quality Of Life and Economic Impact Of Neuropathic Pain and Fibromyalgia Syndrome In Chronic Back Pain Patients In Tertiary Care

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of An Automated Medication System Implemented In A Danish Hospital Setting

    Nov 1, 2016, 00:00

  • Impact of Whole Exome Sequencing (WES) on Costs and Medical Decision-Making

    Nov 1, 2016, 00:00

  • Productivity Loss of Rheumatoid Arthritis Patients By Their Level Of Disease Activity Score

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ixekizumab vs. Secukinumab in Sequential Biologic Treatment of Psoriasis in the UK

    Nov 1, 2016, 00:00

  • Cost of Antihyperglycemic Therapy In Type 2 Diabetes Patients Depending on HBA1C And Bmi Values

    Nov 1, 2016, 00:00

  • France-Spain Comparison of Hospital Delivery Mode Between 2006 And 2014 According Comorbidity Profiles of Patients

    Nov 1, 2016, 00:00

  • Frequency of Occurance of Myocardial Infarction in Hungary Between 2004-2012

    Nov 1, 2016, 00:00

  • Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Russia

    Nov 1, 2016, 00:00

  • How Well is Warfarin Controlled In Real World Clinical Practice in Hong Kong?

    Nov 1, 2016, 00:00

  • Avoidable Hospitalizations Through Effective Primary Care At A Pediatric Hospital In The Colombian Caribbean

    Nov 1, 2016, 00:00

  • Economic Evaluation of Targeted Therapies in Metastatic Clear Renal Cell Carcinoma in Canada

    Nov 1, 2016, 00:00

  • The Role of Weight Loss or Gain In Payer Assessment of Diabetes Drugs

    Nov 1, 2016, 00:00

  • Resource use in Chronic Heart Failure in the UK- A Systematic Review

    Nov 1, 2016, 00:00

  • Treatment Pattern of Antibiotics and Cost Analysis in Sepsis Patients- A Cross Sectional Retrospective Prospective Study

    Nov 1, 2016, 00:00

  • Is utilization of Adjuvant Endocrine Therapy Affected Mainly by Patient Drug Costs? An Analysis of Two Databases

    Nov 1, 2016, 00:00

  • Health Care Costs Among COPD Patients Are Doubled Compared to A Control Population

    Nov 1, 2016, 00:00

  • A Retrospective, Cross Sectional Study on The Prevalence of Hyperuricemia Using A Healthcare Database In Japan

    Nov 1, 2016, 00:00

  • Long-Term Visual Functioning Improvement is Associated with Resolution of Vitreomacular Adhesion in Subjects with Vitreomacular Traction, Including Macular Hole Treated with Intravitreal Ocriplasmin- Results From The Oasis Study

    Nov 1, 2016, 00:00

  • Manufacturers’ And Pharmacists’ Satisfaction with Different Pharmaceutical Distribution Models in Europe

    Nov 1, 2016, 00:00

  • Optimal Design of Pre-Authorization Trials for Effectiveness Evaluation in Severe Asthma

    Nov 1, 2016, 00:00

  • Use of the Pert and Uniform Distributions with the Central Limit Theorem (CLT) to Decrease Variance in Complication Cost Estimation in Probabilistic Models

    Nov 1, 2016, 00:00

  • Availability And Costs Of Pediatric Formulations In India - A Case Study

    Nov 1, 2016, 00:00

  • Non-Adherence to Antihypertensive Drugs- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Swedish Perspective on Health Technology Assessments with Incrementally Lower Costs and Effects

    Nov 1, 2016, 00:00

  • Effects of The Mental Health Parity and Addictions Equality Act on Depression Treatment Choice in Primary Care Facilities in The United States

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Screening for Severe Sleep-Disordered Breathing in Japan

    Nov 1, 2016, 00:00

  • Identification of Adverse Events In Coronary Artery Disease Patients Based on Health-Related Quality of Life Outcome Data

    Nov 1, 2016, 00:00

  • Annual Cost Аnalysis for Medicinal Products for Rare Diseases in Bulgaria

    Nov 1, 2016, 00:00

  • Patient Preferences Versus Physician Perceptions Of Treatment Decisions In Advance Stage Prostate Cancer

    Nov 1, 2016, 00:00

  • Cost-Efficiency Of Clinical Pharmacy Services At Ministry Of Health In Saudi Arabia Application Of American Model

    Nov 1, 2016, 00:00

  • The Clinical and Economic Impact of School-Based Quadrivalent Human Papillomavirus Vaccine on Female or Both Genders in Singapore

    Nov 1, 2016, 00:00

  • Impact of Hypoglycaemic Events on Healthcare Resource Use in Type 2 Diabetes Patients

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure in Greece

    Nov 1, 2016, 00:00

  • Use Of Electronic Health Information Systems (Ehis) By Healthcare Professionals (Hcps) And The Perception Of Its Value In Reducing Medication Risks And Safety For Patients

    Nov 1, 2016, 00:00

  • Value of Expanding Hcv Treatment Capacity in Germany Through Novel, Effective and Shorter Duration Therapies

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of Blood Cultures Among Adult Patients Admitted with Pneumonia in Tianjin, China

    Nov 1, 2016, 00:00

  • Impact of Community Care Subsidies on Care Use Of Elderly People

    Nov 1, 2016, 00:00

  • Cost-Related Medication Nonadherence Among Elderly Medicare Cancer Survivors Using Erythropoiesis-Stimulating Agents

    Nov 1, 2016, 00:00

  • Systematic Review of Cost-Effectiveness Models in Diabetes for Insulin Analogues

    Nov 1, 2016, 00:00

  • Use of Sutureless Prosthesis Neutralizes Expected Worse Economic Impact of High Risk Patients Undergoing Aortic Valve Replacement

    Nov 1, 2016, 00:00

  • The Economic Impact of Schizophrenia from an English NHS Perspective Based on Estimates from Electronic and Self-Reported Methods of Data Collection

    Nov 1, 2016, 00:00

  • How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS

    Nov 1, 2016, 00:00

  • Modeling Treatments and Outcomes in Metastatic Castration-Resistant Prostate Cancer- A Case Study of Discrete Event Simulation and the Challenges for A UK Nice Evaluation

    Nov 1, 2016, 00:00

  • A Systematic Literature Review of Cysteamine Bitartrate Preparations in Patients with Cystinosis

    Nov 1, 2016, 00:00

  • Economic Burden of Ankylosing Spondylitis In Europe. A Systematic Review of The Literature

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Incobotulinumtoxin-A With Flexible Treatment Intervals Compared To Fixed Treatment Intervals In The Management Of Blepharospasm And Cervical Dystonia

    Nov 1, 2016, 00:00

  • The Indirect Costs of Breast Cancer in The Slovak Republic

    Nov 1, 2016, 00:00

  • Comparison of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) and the American Society of Clinical Oncology (Asco) Framework for Assessing Value in Cancer Care

    Nov 1, 2016, 00:00

  • A Restrospective Non-Interventional Study Among Patients with Relapsing Multiple Sclerosis Switching to Fingolimod or to Other Disease Modifying Therapies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Long Acting Granulocyte Colony–Stimulating Factor for Primary Prophylaxis of Febrile Neutropenia in Breast Cancer in The Russia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Biphasic Insulin Aspart 50 Versus Biphasic Human Insulin 50 in People with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • Treatment Gap of Post Osteoporotic Fractures in Taiwan- A Nationwide Cohort Study, 2008-2013

    Nov 1, 2016, 00:00

  • Status and Expenses- Re-Use Of Insulin Syringe Needles in the Diabetic Patients in Beijing

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment of Nintedanib For The Treatment of Idiopathic Pulmonary Fibrosis In The Greek Healthcare System

    Nov 1, 2016, 00:00

  • Universal Mass Vaccination With Phid-Cv Is Cost-Effective In Croatia

    Nov 1, 2016, 00:00

  • Antimicrobial Agents Dispensing In Upper Respiratory Tract, Gastrointestinal Tract Infections And Infected Wound In Thai Drug Stores In 2015

    Nov 1, 2016, 00:00

  • Time to Diabetes Related Complications for Newly Diagnosed Diabetes Patients in Singapore

    Nov 1, 2016, 00:00

  • Systematic Review of the Value of Safety-Engineered Devices in Reducing Needlestick and Sharps Injuries

    Nov 1, 2016, 00:00

  • Markov Models For Health Economic Evaluation Modelling In R With The Heemod Package

    Nov 1, 2016, 00:00

  • Healthcare Costs of Inflammatory Bowel Disease in The Biologic Era- A Study Of 2,451 Patients with Twelve years Follow-Up Evaluation

    Nov 1, 2016, 00:00

  • Prevalence and Patient Characteristics of Multiple Sclerosis (Ms) in Japan

    Nov 1, 2016, 00:00

  • Social And Economic Value of Portuguese Community Pharmacies In Public Health

    Nov 1, 2016, 00:00

  • A Retrospective Premier Database Study to Evaluate Differences Between Progel™ Pleural Air Leak Sealant As Compared with Other Sealants in The Inpatient Surgical Setting

    Nov 1, 2016, 00:00

  • Longitudinal Trajectories of Depressive and Anxious Symptoms Following a Self-Management Intervention for Haemodialysis Patients

    Nov 1, 2016, 00:00

  • Stock Reduction of Erythropoietin for Patients on Hemodialysis at Somdech Phra Debaratana Medical Center

    Nov 1, 2016, 00:00

  • Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in the UK Setting

    Nov 1, 2016, 00:00

  • Indirect Treatment Comparison of Ustekinumab Versus Other Biologics In Moderate To Severe Crohn’s Disease- A 1-Year Treatment Sequence Analysis

    Nov 1, 2016, 00:00

  • Quality of Life of Patients with Alzheimer's Disease - A Comparison with General Population

    Nov 1, 2016, 00:00

  • The assessment of advanced medicinal products (atmp) in germany- is the practice to define atmp drugs as procedures in compliance with european legislation?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Prevenar 13 In Children In Portugal

    Nov 1, 2016, 00:00

  • Towards Improved Cervical Cancer Primary Screening in Austria - A Decision-Analytic Benefit-Harm Analysis

    Nov 1, 2016, 00:00

  • Preference For Cervical Cancer Screening In Rural China- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Early Payer Scientific Advice Procedures In The Eu- Which One Is Most Suited For Pharmaceutical Compaines?

    Nov 1, 2016, 00:00

  • The Impact of Regional Cost-Saving Initiatives on the Uptake of Antiretroviral Drugs in London

    Nov 1, 2016, 00:00

  • Mapping of Existing Data Sources for the Conduct of Real-World Studies on Lung Cancer in China

    Nov 1, 2016, 00:00

  • Translation of the DN4 (Douleur Neuropathique EN 4 Questions) INTO 85 Languages- Challenges and Importance of the Conceptual Defintion of the Original Version

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Brand-Name and Generic Warfarin on Stroke and Bleeding Events in Atrial Fibrillation Patients- A 6-Year Population-Based Retrospective Cohort Study in Taiwan

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Neoadjuvant Pertuzumab and Trastuzumab in Patients with Locally Advanced, Inflammatory, or Early HER-2 Positive Breast Cancer

    Nov 1, 2016, 00:00

  • Assessment of Criteria Influences on Judicious Selection of New Drug for Future Coverage Policy in Iran- An Analysis with Structural Equation Modeling

    Nov 1, 2016, 00:00

  • Pain Management of Lung Cancer Patient in Hungary

    Nov 1, 2016, 00:00

  • Economic Evaluation of Drug Wastage Impact on Healthcare Expenditures in French Hospitals

    Nov 1, 2016, 00:00

  • Evaluating Therapeutic Treatments for Psoriatic Arthritis- Can We Make Better use of Patient Data Registries?

    Nov 1, 2016, 00:00

  • Utilisation and Dosage Patterns of Intravenous Echinocandins for Treatment of Invasive Fungal Infections Within Hospitals in England

    Nov 1, 2016, 00:00

  • The Impact of Dementia on the Outcomes of Treatments For Acute Coronary Syndrome

    Nov 1, 2016, 00:00

  • Assessing The Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Inoperable Patients with Severe Aortic Stenosis in UK

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in the UK

    Nov 1, 2016, 00:00

  • Assessment of Carotid Stenting Safety- A French Exhaustive Cohort Study Based on The Re-Use of Routine National Health Database

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sunitinib Versus Best Supportive Care for The Treatment of Metastatic Renal Cell Carcinoma in Chile

    Nov 1, 2016, 00:00

  • Cost of Illness of Ankylosing Spondylitis In Egypt From Payer Prospective

    Nov 1, 2016, 00:00

  • Benefit Assessment of Medical Devices of High Risk Classes in Germany- Adaptive Approaches to Balance Early Access and Safety and Efficacy Required?

    Nov 1, 2016, 00:00

  • The Cost of Cognitive Impairment in Patient with Major Depressive Disorder

    Nov 1, 2016, 00:00

  • Cost Utility of Transfer Factor In The Treatment of Recurrent Infection`S Episodes In Adult And Pediatric Subjects From A Final Results From Multicentre Observational Study

    Nov 1, 2016, 00:00

  • Diareg – Results from an Diabetes Register with Focus on Patient Reported Outcomes

    Nov 1, 2016, 00:00

  • Exploring The Impact of Adding A Respiratory Dimension to The EQ-5D-5L

    Nov 1, 2016, 00:00

  • Treatment Indications for Antidepressants Prescribed in Primary Care in France, 2006–2015

    Nov 1, 2016, 00:00

  • Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries

    Nov 1, 2016, 00:00

  • What are the Most Important Decision-Making Criteria For Innovative Health Technology Integration? A National Survey from French Hospitals Decision-Makers

    Nov 1, 2016, 00:00

  • Cost - Effectiveness Analysis of Presepsin Compared with C-Reactive Protein and Procalcitonin in Detecting Severe Bacterial Infection in Children Aged 29 Days to 36 Months Old with Fever Without Source

    Nov 1, 2016, 00:00

  • Treatment Patterns And Drug-Related Costs For Patients with Psoriasis on Biologic Therapy- A Retrospective Cohort Study In Southern Italy

    Nov 1, 2016, 00:00

  • Dimensionality Of Value- Are The Us And Europe Moving Towards Similar Or Different Definitions Of Pharmaceutical Value?

    Nov 1, 2016, 00:00

  • Therapeutic Indication of Lyophilized Hydrocortisone to the Treatment of Trichinosis with Neurological and / or Myocardial Involvement

    Nov 1, 2016, 00:00

  • A New Approach to Presenting Health States in Stated Preference Valuation Studies

    Nov 1, 2016, 00:00

  • Exploring The Socioeconomic Impact Of Post Approval Change Requirements For Vaccines

    Nov 1, 2016, 00:00

  • Workload Analysis Of Parenteral Nutrition Services At Ministry Of Health Hospital In Saudi Arabia

    Nov 1, 2016, 00:00

  • Generic Drug Utilization Among The Elderly With Multiple Chronic Conditions In The United States

    Nov 1, 2016, 00:00

  • Relapse Rates and Symptom Management Among Patients Receiving Natalizumab and other Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes in Spondyloarthritis Patients in Europe- A Systematic Review of the Literature

    Nov 1, 2016, 00:00

  • Retrospective Database Analysis of Hospital Length of Stay, Discharge Location, And Readmissions Among Patients Undergoing Total Knee Arthroplasty (TKA) In The United States

    Nov 1, 2016, 00:00

  • Consumer Perception of Communication with Healthcare Professionals (HCPS) and Information Clarity Concerning Newly Prescribed Medication

    Nov 1, 2016, 00:00

  • Impact of Diabetes Management on Diabetes Control and Resource Consumption in Type 2 Diabetic Patients

    Nov 1, 2016, 00:00

  • Real-World Health Outcomes, Economic Impacts, and Cost-Effectiveeness of a Beijing Municipal Government Funded Free-Drug Rpogram in Community Schizophrenia Patients in Beijing, China

    Nov 1, 2016, 00:00

  • When Should Translations of Clinical Outcome Assessments (COAS) be Considered Obsolete? Recommendations from MAPI’S Translations Life Expectancy Working Group

    Nov 1, 2016, 00:00

  • Treatment Resistant Depression Development From Major Depressive Disorder- A Claims Database Analysis In Japan

    Nov 1, 2016, 00:00

  • European Comparison of Spinal Surgery Hospitalizations From 2010 to 2013 According to Patient Profiles

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Lanreotide Autogel 120 Mg in the Treatment of Acromegaly in Poland

    Nov 1, 2016, 00:00

  • Psychometric Validation Of Four Patient-Reported Outcome Instruments In A Diverse Sample Of Adults With Chronic Hepatitis C Virus Infection Treated With Simeprevir And Sofosbuvir

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Interventions on Non-Alcoholic Fatty Liver Disease (NAFLD)- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of Improving Adherence to Diabetes Treatment In Patients with Type 2 Diabetes in Spain

    Nov 1, 2016, 00:00

  • Prevalence of Therapy-Resistant Hypercholesterolemia in High-Risk Cardiovascular Patients in Germany

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los and Costs) of Adhesion Related Complications after Colon Resection Procedures

    Nov 1, 2016, 00:00

  • The Impact of Treatment Adherence on Clinical and Economic Outcomes in Multiple Sclerosis- Real-World Evidence from Alberta, Canada

    Nov 1, 2016, 00:00

  • Efectiveness and Inequality Estimation of Antihypertensive Medicinies` Utilization in Iran According to Observational Data- 2002-2011

    Nov 1, 2016, 00:00

  • Managed Entry Agreements- Portuguese Experience

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis- 4-Year Outcomes from the Rapid-Psa Study

    Nov 1, 2016, 00:00

  • Assessment of CTX-1 Bone Biomarker As An Indicator of Antiresorptive Therapy Efficacy And of Persistence In A Fracture Liaison Service

    Nov 1, 2016, 00:00

  • Validating The Projected Mortality Rates Used in Oncology Cost-Effectiveness Analysis- A Pitfall of Simple Benchmarking With Life Table Age-Specific Mortality Rates for A Trial Population

    Nov 1, 2016, 00:00

  • Cancer Immunotherapy with Checkpoint Inhibitors is Associated with Immune-Mediated Reactions- A Pharmacovigilance Study

    Nov 1, 2016, 00:00

  • How are Budget Impact Considerations Captured within Economic Evaluations? A Systematic Review of the Literature Focused on Rotavirus Vaccine

    Nov 1, 2016, 00:00

  • A UK Observational Cohort Study of Insulin Treatment Patterns and Characterisation of Insulin Users in Type 1 And Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Application Of Quality Indicators To Enable Economic Evaluation Of Quality Improvements – A Bayesian Decision Theoretical And Value Of Information Analytical Framework

    Nov 1, 2016, 00:00

  • Guidance On Selecting Appropriate Methods When Considering Adjusting Overall Survival For Treatment Switch In Oncology Studies

    Nov 1, 2016, 00:00

  • Extra Budgetary Reimbursement Options For Innovations In The German Hospital Sector

    Nov 1, 2016, 00:00

  • An Economic Analysis on Optimal Management of Fragility Hip Fractures In Geriatric Patients Adopting The Geriatric Fracture Program

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Axial Spondyloarthritis Patients, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 4-Year Outcomes from the Rapid-Axs ...

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of A Preventive Testing Strategy in Relatives of Patients with BRCA Mutated Ovarian Cancer Versus A No Test Strategy

    Nov 1, 2016, 00:00

  • The Burden of Illness of Mycosis Fungoides Cutaneous T-Cell Lymphoma- A Retrospective Cohort Study of a Commercially Insured Population in the U.S

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75 (current)
  • 76
  • 77
  • 78
  • 79
  • 80
  • »